Akrevia Taps Joseph Farmer for Chief Operating Officer Post

Joseph Farmer has been appointed chief operating officer of Akrevia Therapeutics. Farmer comes to Cambridge, MA-based Akrevia from Tesaro, a cancer drug developer that was acquired by GlaxoSmithKline (NYSE: [[ticker:GSK]]) earlier this year. His experience also includes posts at Cubist Pharmaceuticals and AMAG Pharmaceuticals. Akrevia launched last year with a $30 million Series A round of funding to back its development of cancer immunotherapies intended to attack tumors in a more targeted way.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.